PortfoliosLab logoPortfoliosLab logo
PRAX vs. PLPC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PRAX vs. PLPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Praxis Precision Medicines, Inc. (PRAX) and Preformed Line Products Company (PLPC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PRAX achieves a 4.44% return, which is significantly lower than PLPC's 73.09% return.


PRAX

1D
0.03%
1M
-3.36%
6M
-1.96%
YTD
4.44%
1Y
469.11%
3Y*
177.75%
5Y*
5.64%
10Y*
ALL TIME*
-3.97%

PLPC

1D
-3.12%
1M
-3.20%
6M
42.44%
YTD
73.09%
1Y
140.70%
3Y*
26.27%
5Y*
40.11%
10Y*
23.71%
ALL TIME*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$34.16M$32.10M$36.11M
$101.21M$111.78M$149.02M

PRAX vs. PLPC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
PRAX
Praxis Precision Medicines, Inc.
4.44%282.98%245.42%-37.59%-87.92%-64.19%112.10%
PLPC
Preformed Line Products Company
73.09%62.61%-3.93%61.77%29.93%-4.34%33.70%

Correlation

The correlation between PRAX and PLPC is 0.12, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.12

Correlation (3Y)
Balances recent behavior with more history.

0.15

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.14

Correlation (All Time)
Calculated using the full available price history since Oct 16, 2020

0.15

Fundamentals

Market Cap

PRAX:

$8.58B

PLPC:

$1.74B

EPS

PRAX:

-$13.35

PLPC:

$8.79

PB Ratio

PRAX:

6.31

PLPC:

3.46

Total Revenue (TTM)

PRAX:

-$92.00K

PLPC:

$740.16M

Gross Profit (TTM)

PRAX:

-$128.83M

PLPC:

$232.70M

EBITDA (TTM)

PRAX:

-$344.68M

PLPC:

$74.44M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PRAX vs. PLPC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

PRAX
PRAX Risk / Return Rank: 9898
Overall Rank
PRAX Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
PRAX Sortino Ratio Rank: 9999
Sortino Ratio Rank
PRAX Omega Ratio Rank: 9898
Omega Ratio Rank
PRAX Calmar Ratio Rank: 9999
Calmar Ratio Rank
PRAX Martin Ratio Rank: 9999
Martin Ratio Rank

PLPC
PLPC Risk / Return Rank: 9393
Overall Rank
PLPC Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
PLPC Sortino Ratio Rank: 9292
Sortino Ratio Rank
PLPC Omega Ratio Rank: 9090
Omega Ratio Rank
PLPC Calmar Ratio Rank: 9393
Calmar Ratio Rank
PLPC Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

PRAX vs. PLPC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Praxis Precision Medicines, Inc. (PRAX) and Preformed Line Products Company (PLPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PRAXPLPCDifference
Sharpe ratioReturn per unit of total volatility

+0.17

Sortino ratioReturn per unit of downside risk

+3.13

Omega ratioGain probability vs. loss probability

1.76

1.36

+0.40

Calmar ratioReturn relative to maximum drawdown

14.46

4.30

+10.17

Martin ratioReturn relative to average drawdown

41.02

15.25

+25.77

PRAX vs. PLPC - Sharpe Ratio Comparison

The current PRAX Sharpe Ratio is 2.37, which is comparable to the PLPC Sharpe Ratio of 2.20. The chart below compares the historical Sharpe Ratios of PRAX and PLPC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PRAX vs. PLPC - Drawdown Comparison

The maximum PRAX drawdown since its inception was -98.67%, which is greater than PLPC's maximum drawdown of -66.36%. Use the drawdown chart below to compare losses from any high point for PRAX and PLPC.


Loading charts...

Drawdown Indicators


PRAXPLPCDifference

Max Drawdown

Largest peak-to-trough decline

-98.67%

-66.36%

-32.31%

Max Drawdown (1Y)

Largest decline over 1 year

-32.61%

-30.91%

-1.70%

Max Drawdown (3Y)

Largest decline over 3 years

-68.64%

-38.50%

-30.14%

Max Drawdown (5Y)

Largest decline over 5 years

-96.50%

-39.35%

-57.15%

Max Drawdown (10Y)

Largest decline over 10 years

-59.49%

Current Drawdown

Current decline from peak

-65.91%

-13.01%

-52.90%

Average Drawdown

Average peak-to-trough decline

-80.22%

-24.75%

-55.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.52%

8.70%

+2.82%

Volatility

PRAX vs. PLPC - Volatility Comparison

The current volatility for Praxis Precision Medicines, Inc. (PRAX) is 14.70%, while Preformed Line Products Company (PLPC) has a volatility of 32.58%. This indicates that PRAX experiences smaller price fluctuations and is considered to be less risky than PLPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PRAXPLPCDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.70%

32.58%

-17.88%

Volatility (6M)

Calculated over the trailing 6-month period

47.26%

49.54%

-2.28%

Volatility (1Y)

Calculated over the trailing 1-year period

199.22%

61.20%

+138.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

127.59%

46.92%

+80.67%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

122.89%

45.50%

+77.39%

Dividends

PRAX vs. PLPC - Dividend Comparison

PRAX has not paid dividends to shareholders, while PLPC's dividend yield for the trailing twelve months is around 0.23%.


PositionTTM20252024202320222021202020192018201720162015
PLPC
Preformed Line Products Company
0.23%0.39%0.63%0.60%0.72%1.24%1.17%1.33%1.47%1.13%1.38%1.90%
PRAX
Praxis Precision Medicines, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PRAX vs. PLPC - Financials Comparison

This section allows you to compare key financial metrics between Praxis Precision Medicines, Inc. and Preformed Line Products Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


PRAX and PLPC have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PLPC has higher volatility (32.58%) compared to PRAX (14.70%). In terms of maximum drawdown, PRAX dropped -98.67% vs PLPC's -66.36%.

PRAX currently has the higher Sharpe Ratio (2.37 vs 2.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PRAX and PLPC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer